Document is current
Any future updates will be listed below
-
Authors
Heidenreich, Silke
Egger-Heidrich, Katharina
Halter, Jörg P. https://orcid.org/0000-0003-4304-1956
Jost, Lasse
Stölzel, Friedrich https://orcid.org/0000-0003-0653-5332
Perl, Markus
Denk, Alexander
Edinger, Matthias
Herr, Wolfgang
Kröger, Nicolaus https://orcid.org/0000-0001-5103-9966
Wolff, Daniel https://orcid.org/0000-0001-7015-3190
Ayuk, Francis https://orcid.org/0000-0001-6297-1847
Fante, Matthias A. https://orcid.org/0009-0008-5662-2630
- License Information
-
More Information
Article History
Received: 4 September 2024
Revised: 2 December 2024
Accepted: 30 December 2024
First Online: 14 January 2025
Competing interests
: S.H. received travel grants from Sanofi and honoraria from Mallinckrodt. F.S. received travel grants from Johnson&Johnson and Servier, and honoraria from JAZZ, Servier, and Pierre Fabre. W.H. received research support from Johnson & Johnson and travel grants from Amgen and Servier. N.K. is a member of the Sanofi advisory board. D.W. received research support from Novartis and honoraria from Novartis, Sanofi, Incyte, Behring, Neovii, Takeda and Mallinckrodt. M.A.F. received honoraria from Sanofi and Novartis and travel grants from Sanofi.
